Q4 2024 Electromed Inc Earnings Call Transcript
Key Points
- Electromed Inc (ELMD) reported record revenue for the third consecutive quarter, with Q4 revenue reaching $14.8 million, a 9% year-over-year growth.
- Annual revenue for fiscal year 2024 was $54.7 million, marking a 14% increase from fiscal year 2023.
- Operating income for both the quarter and the full fiscal year were records, at $2.3 million and $6.6 million, respectively.
- The company successfully reduced its overall inventory to below $4 million for the first time, improving working capital and service rates.
- Electromed Inc (ELMD) expanded its sales team and regional manager team, with plans to increase the US sales team to 57 reps by the end of fiscal year 2025.
- The expiration of the CMS waiver posed a headwind, impacting revenue growth.
- Selling, general, and administrative expenses increased by $2.9 million or 9.2% from the previous year.
- Payroll and compensation-related expenses rose by 14%, driven by increased share-based compensation and higher average number of personnel.
- Travel, meals, and entertainment expenses increased by 11.8%, attributed to a higher number of direct sales representatives and increased travel costs.
- R&D expenses decreased by 28.4%, which could indicate reduced investment in new product development.
Greetings and welcome to the Electromed fourth-quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce you to your host, Mike Cavanaugh, Investor Relations. Thank you, Mike. You may begin.
Good afternoon, and thank you for joining the Electromed earnings call. Earlier today, Electromed Incorporated released financial results for the fourth fiscal quarter of 2024, the quarter ended June 30, 2024. Our release is currently available on the company's website at www.smartvest.com.
Before we get started, I would like to remind everyone that some of the statements that management will make on this call are considered forward-looking statements, including statements about the company's future operating and financial results and plans. Such statements are subject to risks and uncertainties that could cause actual performance or achievements to be materially
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |